We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

18 hedge funds and large institutions have $16.1M invested in Parnell Pharmaceuticals Holdings Ltd in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

20% more funds holding

Funds holding: 15 → 18 (+3)

27% less capital invested

Capital invested by funds: $22.1M → $16.1M (-$5.92M)

88% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 8

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$324K
2
Goldman Sachs
Goldman Sachs
New York
+$209K
3
PA
Perceptive Advisors
New York
+$18.6K
4
Morgan Stanley
Morgan Stanley
New York
+$100

Top Sellers

1
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
California
-$646K
2
PRCM
Pine River Capital Management
Minnesota
-$424K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$163K
4
BG
BlackRock Group
United Kingdom
-$79.3K
5
UOC
UBS O'Connor
Illinois
-$78.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.38M – – –
BA
2
BlackRock Advisors
Delaware
$2.25M -$26.1K -5,753 -1%
AG
3
Artal Group
Luxembourg
$2.08M – – –
DM
4
Deerfield Management
New York
$1.56M -$31.6K -6,945 -2%
AIC
5
AWM Investment Company
New York
$1.13M +$1.24M +273,901 New
BG
6
BlackRock Group
United Kingdom
$1.08M -$79.3K -17,461 -6%
ECM
7
Endurant Capital Management
California
$1.03M +$1.13M +249,427 New
PA
8
Perceptive Advisors
New York
$888K +$18.6K +4,100 +2%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$790K -$32K -7,048 -4%
UOC
10
UBS O'Connor
Illinois
$509K -$78.1K -17,200 -12%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$482K -$163K -35,797 -24%
BIM
12
BlackRock Investment Management
Delaware
$322K -$5.29K -1,165 -1%
JP Morgan Chase
13
JP Morgan Chase
New York
$296K +$324K +71,383 New
Goldman Sachs
14
Goldman Sachs
New York
$191K +$209K +46,100 New
Deutsche Bank
15
Deutsche Bank
Germany
$146K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$3K -$3.24K -714 -47%
UBS Group
17
UBS Group
Switzerland
$1K +$1.14K +251 New
PAAMCP
18
Pacific Alternative Asset Management Company (PAAMCO)
California
– -$646K -112,343 Closed
PRCM
19
Pine River Capital Management
Minnesota
– -$424K -73,653 Closed
Morgan Stanley
20
Morgan Stanley
New York
– +$100 +22 New

PARN Hedge Fund Activity: Q4 2014 in Review

18 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q4 2014, worth a combined $16.1M — down 27% from $22.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PARN positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 8 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $324K. The largest seller was Pacific Alternative Asset Management Company (PAAMCO), exiting entirely with an estimated $646K sold.

  • 18 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q4 2014, up from 15 in Q3 2014.
  • Funds reported $16.1M of Parnell Pharmaceuticals Holdings Ltd stock for Q4 2014, down 27% quarter-over-quarter.
  • 6 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q4 2014 and 2 closed out, a net change of +4 holders.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q4 2014 was JP Morgan Chase, an estimated $324K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q4 2014 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $646K sold.

Based on aggregated 13F filings for Q4 2014.